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408 Letters to the Editordisseminated MAC disease. Similarly, our second patient had
disseminated granulomata despite prolonged antimycobac-
terial therapy following BCG exposure. In both cases, a
persistent immune response to an unknown antigen, possibly
MAC in the first, and BCG in the second patient, resulted in a
steroid-responsive sarcoid-like illness. This occurred in the
first patient only after his cell-mediated immunity had recov-
ered sufficiently to mount such a reaction. Our second
patient was immunocompetent prior to his illness and has
remained well since its resolution.
Both patients responded rapidly to corticosteroids. The
first patient relapsed after withdrawal of prednisone and
required longer maintenance therapy without further treat-
ment for MAC. Prednisone was ultimately discontinued. This
course contrasts with the previously described ‘immune
reconstitution’ syndrome in which improvement occurs
after prolonged antimycobacterial treatment without corti-
costeroids. Our second patient had fever, weight loss and
pancytopenia despite six months of therapy for possible
disseminated BCG infection, and complete resolution
occurred only after corticosteroid therapy. No relapse
occurred following its withdrawal.
Mycobacterial organisms have been isolated from granu-
lomata associated with Crohn’s disease,1,2 or detected by
PCR from cerebrospinal fluid (CSF) of patients with neuro-
sarcoidosis.3 In contrast, there was no evidence of continued
active infection by stain or culture in our two patients. In
each, the presence of prior mycobacterial exposure suggests
that a persistent hypersensitivity reaction to these infections
may have occurred. Corticosteroid-responsive hypersensitiv-
ity granulomatous reactions following BCG infection have
been reported previously in the urologic literature.4,5 Animal
studies have suggested that invasive infection and hypersen-
sitivity may occur simultaneously, requiring both anti-infec-
tive and corticosteroid therapy.6 In recent literature, early
and late reaction to MAC in HIV patients is described.7 Our
experience suggests that similar mechanisms may cause
corticosteroid-responsive granulomatous reactions to both
BCG and MAC infection.
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We report four cases of brucellosis in a family living in Konya
in Turkey.
Case A. A 16-year-old boy was admitted to the hospital
with a fifteen-day history of pain and swelling of the left
knee, fever and difficulty walking. He had a temperature of
38.3 8C, ESR of 40 mm/h, C-reactive protein (CRP) level of
50 mg/dl, and brucella agglutination titer of 1/160. Blood
and synovial fluid cultures were sterile. He was treated
for three weeks with streptomycin and for six weeks with
doxycycline.Case B. His 43-year-old mother presented with complaints
of malaise and anorexia for fifteen days. She had fever,
sweating, rigors and difficulty while walking because of pain
in her hip. She had a temperature of 37.8 8C. The ESR was
55 mm/h. There were osteophytic changes in the tomogra-
phy of the sacro-iliac joint. Brucella agglutination titer was
1/320. Brucella melitensis was isolated from blood cultures
by the BACTEC 9050 culture system. The strain was identified
as biotype I by PCR. The patient was treated for three weeks
with streptomycin and for six weeks with doxycycline.
Forty-five days after completion of the six-week
therapy, the patient re-presented with complaints of pain
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that her temperature was 37.7 8C. The brucella agglutina-
tion test was positive at a titer of 1/640. Blood cultures
were sterile. It was thought to be a relapse of brucellosis
and was treated with streptomycin for three weeks and
for eight weeks with rifampin and doxycycline. Following
this oral therapy, she had physiotherapy and recovered
completely.
Case C. Her 52-year-old husband presented with com-
plaints of high fever, rigors, sweating and pain in the lumbar
region for seven days. He had a temperature of 36.5 8C. The
brucella agglutination titer was 1/320. Blood cultures were
sterile. He was treated for six weeks with doxycycline and
rifampin.
Case D. Her 24-year-old son came to hospital with a
ten-day history of fever, rigors and sweating. He had a
temperature of 37.5 8C. The brucella agglutination titer
was 1/640; blood culture was sterile. He was treated for
six weeks with doxycycline and rifampin.
At review, twelve months after treatment, all patients
remained well.
Brucellosis in members of the same family has been
reported previously.1—4 As brucellosis was determined in
all the family members within a one-month period, a
common source was investigated. The family did not w
ork with animals and they were not used to eating cheese
made from raw milk. Three kinds of cheese that the
family had ingested were cultured but the results were
negative for Brucella spp. Although sexual transmission is
possible between parents of this family, as all the members
were infected, a common source of food was thought to be
the cause.
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doi:10.1016/j.ijid.2005.06.010An unusual presentation of acute brucellosis
with fever, jaundice and maculopapular rash
The clinical features of brucellosis are diverse.1 An uncom-
mon case of brucellosis with the triple conditions of fever,
jaundice and maculopapular rash is described.
A 35-year-old male farmer was admitted to our clinic
because of a seven-day history of fever, jaundice, general-
ized myalgia, fatigue, vomiting, anorexia, sweating and a
maculopapular rash that had appeared one day before
admission. The rash covered the trunk, arms and legs.
Physical examination revealed fever of 39 8C, tachycardia
of 110/min, and blood pressure of 110/90 mmHg. He
had jaundice, rash and hepatosplenomegaly. Laboratory
findings were: white cell count: 6.2  109/L, hematocrit:
37%, platelet count: 45  109/L, erythrocyte sedimentation
rate: 8 mm/h, and C-reactive protein: 7.4 mg/dL (0—
0.5 mg/dL). Biochemical parameters were BUN: 27 mg/dL
(5—23 mg/dL), creatinine: 1.7 mg/dL (0.8—1.4 mg/dL),
total bilirubin: 5.9 mg/dL (0.25—1.2 mg/dL), direct
bilirubin: 2.8 mg/dL (0—0.2 mg/dL), alkaline phosphatase:
502 U/L (64—300 U/L), AST: 486 U/L (10—37 U/L), ALT:
363 U/L (10—37 U/L), and LDH: 3320 U/L (220—450
U/L).Urinalysis revealed a positive result for both protein and
bilirubin. Diffuse enlargement of the spleen and liver were
detected on abdominal ultrasound examination. A chest
X-ray was normal. Antinuclear antibodies, anti-DNA, tuber-
culin skin test, parasitic examinations, and serologic tests
for syphilis, salmonellosis, leptospirosis, rickettsiae, myco-
plasma, toxoplasma, cytomegalovirus, Epstein—Barr virus,
herpes simplex virus, human immunodeficiency virus and
hepatitis B and C viruses were negative. A skin biopsy was
not performed. On admission, a Wright agglutination test
was negative, but after four days, seroconversion at a titer
of 1/320 occurred. One week after hospitalization, blood
and bone marrow cultures for Brucella species were posi-
tive by the BACTEC technique. Doxycycline (200 mg/day)
and streptomycin (1 g/day) were started. The rash disap-
peared within four days of therapy commencement, and
fever resolved on the sixth day of therapy. Antibiotic
therapy continued for six weeks (doxycycline for six weeks
and streptomycin for three weeks). At the 24-week follow
up, the patient had made a full clinical and biochemical
recovery.
Brucellosis is a multi-system disease with a broad spec-
trum of non-specific symptoms that generally occur within
two weeks (but sometimes up to three months) after infec-
tion. Because the clinical illness is nonspecific, a complete
